MAGNETISMM-2: Study of Elranatamab (PF-06863135) in Japanese Participants With Multiple Myeloma

Clinical trial NCT04798586 · COMPLETED

Trial details

NCT number: NCT04798586
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed or Refractory Multiple Myeloma

Start date: 2021-03-22
Primary completion: 2022-05-27
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.